Profile
Curtis Rambaran is currently Chief Medical Officer at Silence Therapeutics Plc since 2023.
Dr. Rambaran was Head-European Translational Medicine at Daiichi Sankyo UK Ltd. from 2016 to 2023.
Dr. Rambaran earned a doctorate from The University of the West Indies.
Curtis Rambaran active positions
| Companies | Position | Start |
|---|---|---|
| SILENCE THERAPEUTICS PLC | Chief Tech/Sci/R&D Officer | 2020-12-31 |
Former positions of Curtis Rambaran
| Companies | Position | End |
|---|---|---|
Daiichi Sankyo UK Ltd.
Daiichi Sankyo UK Ltd. Medical DistributorsDistribution Services Wholesales pharmaceutical products | Corporate Officer/Principal | 2023-11-30 |
Training of Curtis Rambaran
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Silence Therapeutics Plc
Silence Therapeutics Plc Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of novel pharmaceutical products | Commercial Services |
The University of the West Indies
The University of the West Indies Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Daiichi Sankyo UK Ltd.
Daiichi Sankyo UK Ltd. Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
- Stock Market
- Insiders
- Curtis Rambaran
















